Healthpeak Properties, Inc. (DOC) · Aug 4, 2026 · Earnings

FFO beat and guidance rose, but core outpatient trends stayed soft

Beat — adj. FFO $0.46 vs ~$0.44 consensus; FY guide midpoint up $0.02

FFO beat and guidance rose, but core outpatient trends stayed soft

The quarter cleared the main earnings bar. Adjusted FFO was $0.46 per share, two cents above the published consensus of roughly $0.44. GAAP EPS was $0.08 versus $0.05 a year earlier, but the more relevant REIT measure was essentially flat year over year at the adjusted-FFO level.

MetricQ2 2026ComparisonRead
Adjusted FFO per share$0.46~$0.44 consensusBeat
Total revenue$771.6M$694.3M in Q2 2025Higher, largely reflecting senior housing consolidation
Adjusted FFO per share$0.46$0.46 in Q2 2025Flat year over year
FY 2026 adjusted FFO guidance$1.73–$1.77$1.71–$1.75 previouslyMidpoint +$0.02
FY 2026 same-store cash NOI growth0%–1.5%(1)%–1% previouslyRange improved by 75 bps

Management raised the outlook rather than merely reaffirming it. The full-year adjusted-FFO range moved to $1.73–$1.77 from $1.71–$1.75, while same-store cash NOI guidance shifted from a possible decline to a 0%–1.5% gain. That is the clearest incremental signal in the filing and supports a modestly better-than-expected operating picture. (Guidance)

The underlying portfolio is mixed, not uniformly improving. Q2 same-store adjusted NOI reached $335.4 million versus $329.4 million a year earlier, but outpatient medical same-store adjusted NOI was $189.1 million versus $184.5 million, while lab was $114.2 million versus $118.0 million. Senior housing improved to $32.1 million from $26.9 million, making that segment a major offset to lab weakness. (Segment results — Total Portfolio; Segment results — Outpatient Medical, Lab, and Senior Housing)

Capital allocation was the stronger strategic takeaway. Healthpeak generated approximately $1.75 billion of year-to-date proceeds, including roughly $1.025 billion from selling a 49% interest in the Brookfield outpatient medical joint venture, then used proceeds to repay $650 million of senior notes and approximately $375 million of commercial paper. The balance sheet ended June with $1.63 billion of cash and 37.8% financial leverage, although the Brookfield transaction and debt actions were largely previously disclosed rather than fresh surprises. (Capital allocation; Balance Sheet / Debt metrics)

Net: a narrow beat with a better outlook, tempered by uneven same-store performance. The consensus comparison favors a positive read, but the quarter itself did not show broad organic acceleration: adjusted FFO was flat year over year, outpatient growth was modest, and lab remained under pressure. The guidance increase and balance-sheet strengthening are what lift the filing above merely in line. (Financial Highlights; Guidance)

Original filing on SEC EDGAR

More Healthpeak Properties, Inc. news

FFO beat and guidance rose, but core outpatient trends stayed soft | DOC Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.